CTRI/2017/12/010906
Recruiting
未知
An observational study to describe the clinical impact (seizure freedom for 12 months) of clobazm (Frisium®) as an adjunct therapy in patients who are not adequately stabilized with their anticonvulsant monotherapy - ADD O
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- EpilepsyHealth Condition 2: G409- Epilepsy, unspecified
- Sponsor
- Sanofi India Limited
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patient more than equal to 3 years of age
- •2\. Investigator decides to prescribing Frisium as an adjunctive therapy in patients with epilepsy who are not adequately stabilized
- •3\. Signed Informed Consent obtained from the patients or legally acceptable representative prior to any study related procedure
- •Note\-Frisium would be prescribed by the Investigator based on his/her clinical judgement.This study will not influence the Investigators decision to either prescribe or not to prescribe Frisium.If the patient is prescribed Frisium and if he/she satisfies all the inclusion and exclusion criteria, he/she may be recruited in this study.
Exclusion Criteria
- •1\. Patient with a known hypersensitivity to clobazam or any of the excipients of Frisium 2\. Patient with any history of drug or alcohol dependence 3\. Patient with known case of myasthenia gravis, severe respiratory insufficiency, sleep apnoea syndrome or severe impairment of liver/ renal function 4\. Patient with recognized epilepsy syndrome 5\. Patient and/or caretaker will not be able to complete the patients diary
- •6\. Patient participating in any clinical trial or was part of a clinical trial in the last 3 months 7\. Patient who is pregnant or breastfeeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
nderstanding the importance of adipokines in patients with lymphoma (blood cancer) in the clinical setupHealth Condition 1: C858- Other specified types of non-Hodgkin lymphomaCTRI/2021/01/030799JAMIA HAMDARD62
Not yet recruiting
Not Applicable
iver Cancer data collection in Indian population .Health Condition 1: C220- Liver cell carcinomaCTRI/2019/12/022387Asian Institute of Gastroenterology
Not yet recruiting
Phase 2
Effect of Mashapinda Svedana on Muscle Wasting in Neuromuscular DisordersCTRI/2024/05/066992J S Ayurveda Mahavidyala
Active, not recruiting
Phase 1
A clinical observational study to assess the effectiveness of Strontium Ranelate on bone protection in osteoporotic patients pre-treated with bisphosphonates. - Strontium following bisphosphonate therapyPostmenopausal OsteoporosisMedDRA version: 8.1 Level: LLT Classification code 10031285 Term: Osteoporosis postmenopausalEUCTR2005-003138-16-GBR+ D department, Hull and East Yorkshire NHS Hospital Trust
Recruiting
Not Applicable
An observational clinical study to assess and assessment of the risk of bleeding after dentoalveolar procedures with Medication with direct oral anticoagulants (DOAKs), antiplatelet agents, and vitamin K antagonists.D68.33Z92.1D68.35Personal history of long-term (current) use of anticoagulantsDRKS00024889Mund-Kiefer- und Gesichtschirurgische KlinikFAU Uniklinik Erlangen300